B. Demirkan Et Al. , "Human epidermal growth factor receptor 2 (HER2) testing in operable breast cancer: comparison of immunohistochemistry (IHC), fluorescent in situ hybridization (FISH), chromogenic in situ hybridization (CISH), and quantitative real-time polymerase chain reaction (qRT-PCR)," 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology , vol.7, Berlin, Germany, pp.99-100, 2009
Demirkan, B. Et Al. 2009. Human epidermal growth factor receptor 2 (HER2) testing in operable breast cancer: comparison of immunohistochemistry (IHC), fluorescent in situ hybridization (FISH), chromogenic in situ hybridization (CISH), and quantitative real-time polymerase chain reaction (qRT-PCR). 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology , (Berlin, Germany), 99-100.
Demirkan, B., CİNGÖZ, S., Cavusoglu, A., Kilic, Y., Canda, T., Sakizli, M., ... Saydam, S.(2009). Human epidermal growth factor receptor 2 (HER2) testing in operable breast cancer: comparison of immunohistochemistry (IHC), fluorescent in situ hybridization (FISH), chromogenic in situ hybridization (CISH), and quantitative real-time polymerase chain reaction (qRT-PCR) . 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology (pp.99-100). Berlin, Germany
Demirkan, B. Et Al. "Human epidermal growth factor receptor 2 (HER2) testing in operable breast cancer: comparison of immunohistochemistry (IHC), fluorescent in situ hybridization (FISH), chromogenic in situ hybridization (CISH), and quantitative real-time polymerase chain reaction (qRT-PCR)," 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology, Berlin, Germany, 2009
Demirkan, B. Et Al. "Human epidermal growth factor receptor 2 (HER2) testing in operable breast cancer: comparison of immunohistochemistry (IHC), fluorescent in situ hybridization (FISH), chromogenic in situ hybridization (CISH), and quantitative real-time polymerase chain reaction (qRT-PCR)." 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology , Berlin, Germany, pp.99-100, 2009
Demirkan, B. Et Al. (2009) . "Human epidermal growth factor receptor 2 (HER2) testing in operable breast cancer: comparison of immunohistochemistry (IHC), fluorescent in situ hybridization (FISH), chromogenic in situ hybridization (CISH), and quantitative real-time polymerase chain reaction (qRT-PCR)." 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology , Berlin, Germany, pp.99-100.
@conferencepaper{conferencepaper, author={B. Demirkan Et Al. }, title={Human epidermal growth factor receptor 2 (HER2) testing in operable breast cancer: comparison of immunohistochemistry (IHC), fluorescent in situ hybridization (FISH), chromogenic in situ hybridization (CISH), and quantitative real-time polymerase chain reaction (qRT-PCR)}, congress name={15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology}, city={Berlin}, country={Germany}, year={2009}, pages={99-100} }